Unintentional cannabis exposures in children pre- and post-legalization: A retrospective review from a Canadian paediatric hospital.

Health Policy Injury Paediatrics Poisoning Public Health

Journal

Paediatrics & child health
ISSN: 1205-7088
Titre abrégé: Paediatr Child Health
Pays: England
ID NLM: 9815960

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 11 06 2021
accepted: 10 11 2021
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 27 8 2022
Statut: epublish

Résumé

Canada legalized recreational cannabis in October 2018. Cannabis is increasingly available in numerous forms-especially edibles-that make children vulnerable to unintentional intoxication. We sought to: determine the frequency of visits due to cannabis intoxication pre- and post-legalization; characterize the clinical features and circumstances of cannabis intoxication in the paediatric population; and create greater awareness among healthcare providers about this issue. We performed a retrospective chart review of Emergency Department visits at the Children's Hospital of Eastern Ontario (Ottawa, ON) between March 2013 and September 2020. Inclusion criteria were: age <18 years; unintentional cannabis ingestion, identified by ICD-10 codes T40.7 and X42. We assessed basic demographics, clinical signs and symptoms, exposure details, investigations, and patient disposition. A total of 37 patients (22 male) met inclusion criteria, mean age 5.9±3.8 years. Most visits (32; 86%) occurred in the 2-year period after legalization. Altered levels of consciousness, lethargy/somnolence, tachycardia, and vomiting were the most common presenting signs and symptoms. The majority of exposures were to edibles (28; 76%) in the home setting (30; 81%). Poison control and child protective services were involved in 19 (51%) and 22 (59%) of cases, respectively. Twelve patients (32%) required admission to the hospital, the majority of whom stayed <24 h. Our data confirm increased paediatric hospital visits related to unintentional cannabis exposures post-legalization. Consideration of this clinical presentation is critical for acute care providers. Advocacy for safe storage strategies and appropriate enforcement of marketing/packaging legislation are imperative for public health policymakers.

Identifiants

pubmed: 36016591
doi: 10.1093/pch/pxab090
pii: pxab090
pmc: PMC9394633
doi:

Types de publication

Journal Article

Langues

eng

Pagination

265-271

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Innov Clin Neurosci. 2019 Mar 1;16(3-4):16-18
pubmed: 31214478
Inj Prev. 2020 Apr;26(2):184-186
pubmed: 31676510
Paediatr Child Health. 2017 May;22(2):98-102
pubmed: 29480902
J Pediatr. 2017 Nov;190:142-152
pubmed: 28888560
J Pediatr. 2020 Apr;219:254-258.e1
pubmed: 31952846
J Emerg Med. 2019 Jan;56(1):94-96
pubmed: 30340924
Pediatr Emerg Care. 2019 Nov;35(11):799-804
pubmed: 31688799
Emergencias. 2018 Dic;30(6):408-411
pubmed: 30638345
Curr Opin Pediatr. 2019 Jun;31(3):291-296
pubmed: 31090567
Eur J Pharmacol. 2008 May 13;585(2-3):441-52
pubmed: 18413273
Health Policy. 2018 Mar;122(3):205-209
pubmed: 29429644
Eur J Pediatr. 2017 Apr;176(4):553-556
pubmed: 28210835
Pediatr Emerg Care. 2021 Oct 1;37(10):e594-e598
pubmed: 30601351
Mo Med. 2018 Sep-Oct;115(5):398-404
pubmed: 30385981
Ann Emerg Med. 2018 Mar;71(3):306-313
pubmed: 29103798
Pediatr Emerg Care. 2020 Jun;36(6):e349-e354
pubmed: 29406477
Ann Intern Med. 2019 Jan 15;170(2):124
pubmed: 30615784
CJEM. 2016 Nov;18(6):480-483
pubmed: 27780499
Health Promot Chronic Dis Prev Can. 2020 Jun;40(5-6):193-200
pubmed: 32529979
Br J Psychiatry. 2001 Feb;178:101-6
pubmed: 11157422

Auteurs

Alon Coret (A)

Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.

Anne Rowan-Legg (A)

Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.

Classifications MeSH